Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

  • Price (USD)0.876
  • Today's Change-0.002 / -0.23%
  • Shares traded1.07m
  • 1 Year change-8.56%
  • Beta0.2701
Data delayed at least 20 minutes, as of Apr 25 2024 17:17 BST.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+3.90%
NAVBioPharma Credit PLC (Ordinary Share)+8.23%
Morningstar's BenchmarkNo benchmark--

Key statistics

On Thursday, BioPharma Credit PLC (BPCR:LSE) closed at 0.876, 8.15% above its 52-week low of 0.81, set on Nov 09, 2023.
52-week range
Today
0.81Nov 09 20230.966May 17 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.23bn
Market cap1.08bn USD
Total assets1.21bn USD
Total expense ratio1.15%
High0.878
Low0.874
Previous close0.878
Average volume2.53m
YTD Change+4.29%
Beta0.2701
Diluted NAV (est)0.985
Diluted NAV (last pub)0.98
Premium/Discount-11.07%
Net Gearing0.00%
Annual div (ADY)0.070 USD
Annual div yield (ADY)7.97%
Div ex-dateMar 28 2024
Div pay-dateApr 30 2024
Data delayed at least 20 minutes, as of Apr 25 2024 17:17 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.